Abbott will be importing 1.1 million pounds of powder infant formula to the U.S. from our manufacturing facility in Granada, Spain, beginning this month through this summer, after receiving enforcement discretion from the U.S. Food and Drug Administration (FDA). These shipments will include powder Similac Total Comfort (for babies with sensitive stomachs) and Similac NeoSure (for premature and low birthweight infants after leaving the hospital), the equivalent of 686,350 cans or more than 16.5 million 8 fl. oz. bottles of formula.
The company appreciates the support of the Administration and FDA for making it possible to ship product from manufacturing locations outside the U.S.
The formula will be available for purchase through similac.com and other online retailers once it arrives. Logistical details and product availability are being finalized and will be updated as soon as the information is available.
A portion of the inventory will be provided as emergency samples to areas of the country experiencing low supply for the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) program.
The products were manufactured in our facility in Granada, Spain, under European Union Good Manufacturing Practices and have undergone microbiological testing prior to release. The Granada facility has been producing a wide portfolio of powder products for infants and adults for more than 30 years and for distribution to more than 50 markets around the world.
This statement was originally published by Abbott.